Kingspan passes 30% mandatory bid threshold Will bid SEK 160/sh, (13.
Redeye comments on the recent development concerning the Digital Markets Act (DMA).
Redeye comments on Jondetech's announcement of a rights issue, a bridge loan, and termination of the...
At ChromoGenics AB's annual general meeting on 21 June 2023, a decision was made to undergo a revers...
This morning, Fiskars announced its plans to simplify its organizational structure to speed up the c...
Redeye shares its thoughts on Arise’s new financial targets communicated on 12 September in conjunct...
Industrikoncernen, VIMAB Group, redovisade en nettoomsättning om 89,2 (70,7) miljoner kronor under d...
Gold Town Games AB (”Gold Town Games” eller ”Bolaget”) uppvisade under årets andra kvartal en fortsa...
Genom en förbättrad produktionsprocess av Carbiotix AB:s (”Carbiotix” eller Bolaget”) prebiotiska fi...
Fortsatt fokus på BupiZenge OncoZenge levererade nyligen sin rapport för det andra kvartalet.
Rightbridge Ventures Group AB (”Rightbridge”, ”RBV” eller ”Bolaget”) är ett compounder- och investme...
Redeye comments on Ependion’s energy contract, confirming our positive stance on the segment, not le...
On 11 September, Atria issued a positive profit warning.
Redeye leaves a short comment on Xspray following today's exciting news that Xspray and Bristol Myer...
Redeye comments on today’s news that Coala Life is initiating a cost-reduction program to reduce the...
PolarCool AB (”PolarCool” eller Bolaget”) är ett medtech-bolag som har utvecklat en unik högkvalitat...
Under de senaste månaderna har NOSIUM kommunicerat flera nyheter och det är tydligt att aktiviteten ...
Today, Medivir communicated that its Partner Tango Therapeutics has received the approval to start a...
Nettoomsättningen ökade och resultatet förbättrades.
Redeye provides its Q2 2023 sector update for the Nordic SaaS space.